Baseline Characteristics of Patients Diagnosed with Systemic Lupus Erythematosus Initiating Treatment with Intravenous Belimumab

被引：0
|
作者：
Bell, Christopher F. [1 ]
Priest, Julie [1 ,2 ,3 ]
Amelio, Justyna [4 ]
Song, Xue [5 ]
Kan, Hong [6 ]
Stott-Miller, Marni [7 ]
Limone, Brendan [5 ]
Noxon, Virginia [5 ]
Costenbader, Karen H. [8 ,9 ]
机构：
[1] GSK US Value Evidence & Outcomes, Res Triangle Pk, NC USA
[2] US Hlth Outcomes, Durham, NC USA
[3] ViiV Healthcare, Durham, NC USA
[4] GSK Real World Evidence & Epidemiol, Stevenage, Herts, England
[5] Truven Hlth Analyt, Ann Arbor, MI USA
[6] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA
[7] GSK Real World Evidence & Epidemiol, Uxbridge, Middx, England
[8] Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, 75 Francis St, Boston, MA 02115 USA
[9] Harvard Med Sch, Boston, MA USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2017年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2593
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Frequency of Infusions Among Patients Diagnosed with Systemic Lupus Erythematosus Initiating Treatment with Intravenous Belimumab
    Bell, Christopher F.
    Priest, Julie
    Stott-Miller, Marni
    Kan, Hong
    Amelio, Justyna
    Song, Xue
    Limone, Brendan
    Noxon, Virginia
    Costenbader, Karen H.
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [2] Characteristics of Patients Diagnosed with Systemic Lupus Erythematosus (SLE) Initiating Treatment with Belimumab in a US Commercially Insured Database: 2010-2014
    Hill, Deanna
    Kan, Hong
    Egger, Peter
    Chang, David J.
    Eudy, Amanda
    Maskell, Joe
    Costenbader, Karen H.
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [3] BASELINE PROFILE OF SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS ON TREATMENT WITH BELIMUMAB OF A SPANISH MULTICENTER COHORT
    Altabas Gonzalez, I.
    Pego-Reigosa, J. M.
    Hernandez-Martin, A.
    Font, J.
    Casafont-Sole, I.
    Roman Ivorra, J. A.
    De la Rubia Navarro, M.
    Galindo, M.
    Salman Monte, T. C.
    Narvaez, J.
    Vidal Montal, P.
    Garcia Villanueva, M. J.
    Fernandez Cid, C. Marras
    Piqueras Garcia, M. M.
    Martinez-Barrio, J.
    Sanchez Lucas, M.
    Cortes-Hernandez, J.
    Penzo, E.
    Calvo-Alen, J.
    De Dios, J. R.
    Tomero Muriel, E.
    Menor-Almagro, R.
    Gandia Martinez, M.
    Gomez-Puerta, J. A.
    Frade-Sosa, B.
    Ramos Giraldez, C.
    Trapero, C.
    Munoz Jimenez, A.
    Moriano, C.
    Diez Alvarez, E.
    Jimenez, N.
    Rua-Figueroa, I.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1461 - 1462
  • [4] Belimumab for the treatment of systemic lupus erythematosus
    Jordan, Natasha
    D'Cruz, David P.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2015, 11 (02) : 195 - 204
  • [5] The safety of belimumab for the treatment of systemic lupus erythematosus
    Wise, Leanna M.
    Stohl, William
    EXPERT OPINION ON DRUG SAFETY, 2019, 18 (12) : 1133 - 1144
  • [6] Subcutaneous belimumab in the treatment of systemic lupus erythematosus
    Elalouf, Ofir
    Keeling, Stephanie O.
    Touma, Zahi
    IMMUNOTHERAPY, 2018, 10 (13) : 1163 - 1173
  • [7] Population Pharmacokinetics of Belimumab Following Intravenous Administration in Patients With Systemic Lupus Erythematosus
    Struemper, Herbert
    Chen, Cecil
    Cai, Wendy
    JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 53 (07): : 711 - 720
  • [8] Subcutaneous and intravenous belimumab in the treatment of systemic lupus erythematosus: a review of data on subcutaneous and intravenous administration
    Poh, Y. J.
    Baptista, B.
    D'Cruz, David P.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2017, 13 (10) : 925 - 938
  • [9] Healthcare Resource Utilization and Costs in Patients with Systemic Lupus Erythematosus before and after Initiating Treatment with Intravenous Belimumab: A US Claims Database Analysis
    Bell, Christopher F.
    Priest, Julie
    Stott-Miller, Marni
    Kan, Hong
    Amelio, Justyna
    Song, Xue
    Limone, Brendan
    Noxon, Virginia
    Costenbader, Karen H.
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [10] THE PLUTO STUDY: INTRAVENOUS BELIMUMAB IN CHILDREN WITH SYSTEMIC LUPUS ERYTHEMATOSUS
    Ruperto, Nicolino
    Abud-Mendoza, Carlos
    Viola, Diego O.
    Calvo, Inmaculada
    Levy, Deborah M.
    Gallegos, Julia Calderon
    Ferrandiz, Manuel
    Chasnyk, Vyacheslav
    Keltsev, Vladimir
    Anton, Jordi
    Gastanaga, Maria
    Shishov, Michael
    Boteanu, Alina
    Henrickson, Michael
    Bass, Damon
    Clark, Ken
    Hammer, Anne
    Ji, Beulah
    Nino, Antonio
    Roth, David
    Struemper, Herbert
    Wang, Mei-Lun
    Martini, Alberto
    Lovell, Daniel J.
    Brunner, Hermine
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 764 - 765
12345